Table 2. Inclusion criteria.

1)Diagnosed either as HeFH, HoFH, type III hyperlipoproteinemia, familial chylomicronemia, sitosterolemia, CTX, LCAT deficiency, Tangier disease, APOA1 deficiency, and abetalipoproteinemia, according to the criteria set by Japan Atherosclerosis Society or the Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labor and Welfare of Japan.

2)Provide written informed consent.